Shattuck Labs (STTK) Cash from Operations (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Cash from Operations of 13424000.0 for Q1 2026, down 11.57% year-over-year from 15180222.56 in Q1 2025, and down 58.12% quarter-over-quarter from 8490000.0 in Q4 2025.
Powered by 
Analysis
Shattuck Labs (STTK) Cash from Operations (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Cash from Operations for 8 consecutive years, with 13424000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 11.57% year-over-year to 13424000.0; the TTM figure through Mar 2026 stood at 41274000.0 (up 26.8% YoY), while the FY2025 annual figure was 39882000.0, up 34.1% from the prior year.
- Cash from Operations retreated to 13424000.0 in Q1 2026 per STTK's latest filing, from 8490000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8490000.0 in Q4 2025 and bottomed at 28064000.0 in Q3 2022.
- Historically, Cash from Operations has averaged 17032176.47 across 5 years, with a median of 16316000.0 in 2022.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 137.41% — and 2025, when it jumped 51.12%.
- Shattuck Labs' Cash from Operations stood at 23841000.0 in 2022, then grew by 18.55% to 19419000.0 in 2023, then increased by 10.55% to 17370000.0 in 2024, then surged by 51.12% to 8490000.0 in 2025, then slumped by 58.12% to 13424000.0 in 2026.
- Business Quant data shows STTK's Cash from Operations at 13424000.0 in Q1 2026, 8490000.0 in Q4 2025, and 8929000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Shattuck Labs | 885.09 Mn | 885.09 Mn | - | -10.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.19 Mn |
| Mar 31, 2026 | -13.42 Mn |
| Dec 31, 2025 | -8.49 Mn |
| Sep 30, 2025 | -8.93 Mn |
| Jun 30, 2025 | -10.43 Mn |
| Mar 31, 2025 | -12.03 Mn |
| Dec 31, 2024 | -17.37 Mn |
| Sep 30, 2024 | -16.07 Mn |
| Jun 30, 2024 | -10.92 Mn |
| Mar 31, 2024 | -16.16 Mn |
| Dec 31, 2023 | -19.42 Mn |
| Sep 30, 2023 | -16.73 Mn |
| Jun 30, 2023 | -18.62 Mn |
| Mar 31, 2023 | -26.46 Mn |
| Dec 31, 2022 | -23.84 Mn |
| Sep 30, 2022 | -28.06 Mn |
| Jun 30, 2022 | -16.32 Mn |
| Mar 31, 2022 | -26.28 Mn |
| Dec 31, 2021 | -18.72 Mn |
| Sep 30, 2021 | -12.99 Mn |